Corporate Overview
LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision, proudly based in San Diego. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia.
Latest Financial Results
Q1 2024
Quarter Ended Mar 31, 2024
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2023
Report Links
Email Alerts
Get the latest news and reports delivered right to your inbox.
Sign Up TodayIR Contacts
Corporate
LENZ Therapeutics, Inc.
445 Marine View Ave.
Suite 320
Del Mar, CA 92014
T: 858-925-7000
contact@lenz-tx.com
Investor Relations
LENZ Therapeutics
IR@LENZ-Tx.com
Stern Investor Relations, Inc.
Janhavi Mohite
janhavi.mohite@sternir.com
Transfer Agent
Equiniti Trust Company, LLC
48 Wall Street
New York, NY 10005
T: 800-937-5449